Reported 0 shares, down 1,075,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-09-30 | 1121930 |
| 2023-12-31 | 2548425 |
| 2024-03-31 | 0 |
| 2024-06-30 | 3236900 |
| 2024-09-30 | 0 |
| 2024-12-31 | 2752500 |
| 2025-03-31 | 931700 |
| 2025-06-30 | 729831 |
| 2025-09-30 | 944656 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -1,075,000 (-100.0%) | 0 | $0 | 2026-02-17 | |
| Q3 2025 | Added | 1,075,000 | +75,000 (7.5%) | < 0.01% | $944,656 | 2025-11-14 | |
| Q2 2025 | Unchanged | 1,000,000 | 0 (0.0%) | < 0.01% | $729,831 | 2025-08-14 | |
| Q1 2025 | Reduced | 1,000,000 | -1,500,000 (-60.0%) | < 0.01% | $931,700 | 2025-05-15 | |
| Q4 2024 | New | 2,500,000 | +2,500,000 (0.0%) | < 0.01% | $2,752,500 | 2025-02-14 | |
| Q3 2024 | Reduced | 0 | -2,506,000 (-100.0%) | 0 | $0 | 2024-11-14 | |
| Q2 2024 | New | 2,506,000 | +2,506,000 (0.0%) | < 0.01% | $3,236,900 | 2024-08-14 | |
| Q1 2024 | Reduced | 0 | -2,500,000 (-100.0%) | 0 | $0 | 2024-05-14 | |
| Q4 2023 | Added | 2,500,000 | +1,500,000 (150.0%) | < 0.01% | $2,548,425 | 2024-02-13 | |
| Q3 2023 | New | 1,000,000 | +1,000,000 (0.0%) | < 0.01% | $1,121,930 | 2023-11-14 |
Who else reported the position
34 managers reported SAREPTA THERAPEUTICS INC for Q4 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Added | 57,306,000 | +20,306,000 | 1.65% | $51,747,318 | 10 qtrs |
| DG Capital Management LLC | Added | 22,245,000 | +250,000 | 8.75% | $19,954,210 | 2 qtrs |
| D E Shaw & Co Inc | Reduced | 16,897,000 | -14,000,000 | < 0.01% | $15,239,048 | 3 qtrs |
| Calamos Advisors LLC | Reduced | 15,000 | -13 | 0.05% | $13,531,050 | 10 qtrs |
| LMR Partners LLP | Added | 14,300,000 | +4,300,000 | 0.02% | $12,899,601 | 2 qtrs |
| ADVENT CAPITAL MANAGEMENT DE | New | 10,085,000 | +10,085,000 | 0.18% | $9,033,290 | 1 qtr |
| BNP Paribas Asset Management Holding S A | Reduced | 3,500,000 | -900,000 | < 0.01% | $3,147,000 | 8 qtrs |
| STATE OF WISCONSIN INVESTMENT BOARD | Unchanged | 3,000,000 | 0 | < 0.01% | $2,668,500 | 3 qtrs |
| PALISADE CAPITAL MANAGEMENT LLC NJ | Reduced | 1,746,000 | -1,559,000 | 0.05% | $1,571,400 | 10 qtrs |
| FMR LLC | Unchanged | 0 | 0 | < 0.01% | $1,293,333 | 10 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2025
- Filed
- February 17, 2026
- Filing type
- 13F-HR
- Position type
- Convertible
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.